Amniotic Membrane Market By Type (Cryopreserved Amniotic Membrane & Dehydrated Amniotic Membrane), By Application (Ophthalmology, Surgical Wounds Repairment, & Others), By End-Users (Hospitals, Ambulatory Surgical Centers, Private Clinics, & Others) - Global Opportunity Analysis & Industry Forecast, 2022-2027

Report Code: HCR 60265 Report Format: PDF + Excel

Amniotic Membrane Market Overview

The Amniotic Membrane Market size is estimated to reach $1.15 billion by 2027 and is poised to grow at a CAGR of 7.8% over the forecast period of 2022-2027. The amniotic membrane is an avascular fetal membrane, which lies deep down the chorion, and is usually harvested in a sterile environment, particularly from the placental tissue in the cesarean procedures. After opting for the following procedure, the elected donor is screened for transmissible diseases, following which amnion is treated with a broad spectrum of antibiotics. The amnion is made up of three layers- epithelium, basement membrane, and lastly, the stroma. Furthermore, amniotic membrane transplantation is widely used as a graft in various surgeries, making it of utmost use in the field of ophthalmology. Moreover, membrane transplantation is being used in various subspecialties. Additionally, technologies such as PROKERA are being rapidly made accessible to the world around. It is a medical device used to protect, repair, and even heal damaged surfaces of the eyes. Owing to a surge in the R&D-related activities in stem cell and regenerative medicine along with the properties of amniotic membrane in reducing pain and improving the healing process are some of the factors driving the Amniotic Membrane Industry forward in the forecast period.

Report Coverage

The report: Amniotic Membrane Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Amniotic Membrane Market.

By Type- Cryopreserved Amniotic Membrane and Dehydrated Amniotic Membrane.
By Application- Ophthalmology, Surgical Wounds Repairment, and Others.
By End-Users- Hospitals, Ambulatory Surgical Centers, Private Clinics, and Others.
By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key Takeaways

  • Geographically, North America’s amniotic membrane market held a dominant market share in the year 2021. It is owing to an increase in the healthcare expenditure supplemented by the rising R&D investments across the new ventures. And lastly, a surge in the ASCs has aided the market hold. Moreover, Asia-Pacific is estimated to offer lucrative growth opportunities to the marketers owing to an increase in the geriatric population and their need for having eye surgeries.
  • An increase in the cases of ophthalmic surgeries supplemented with old age is the key market driver. However, the side effects post surgeries have impeded the market growth.
  • A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Amniotic Membrane Market Report.

    Amniotic Membrane Market- Geography (%) for 2021

    Amniotic Membrane Market

    For More Details on This Report - Request for Sample

Amniotic Membrane Market Segmentation Analysis - By Type

The amniotic membrane market based on type can be further segmented into Cryopreserved Amniotic Membrane and Dehydrated Amniotic Membrane. Cryopreserved Amniotic Membrane held a dominant market share in the year 2021. The cryopreservation technique is based on slow-freezing, usually at -80 degrees, thereby also using DMEM or glycerol, to not form ice. Owing to the following technique, it retains extracellular matrix components, such as heavy-chain hyaluronic acids, growth factors, fibronectin, and collagen, all of which promote anti-inflammatory effects and healing.

Moreover, the cryopreserved amniotic membrane segment is estimated to be the fastest-growing, with a CAGR of 8.4% over the forecast period of 2022-2027. It is owing to the predominant product launches and advances being made in the following segment. The cryopreserved amniotic membrane is obtained from the C-sections, whose numbers are growing. The worldwide C-sections procedure has zoomed from 7% in 1990 to 21% in 2021, and WHO predicts for it to rise in the coming decades, thereby facilitating the overall growth of the market.

Amniotic Membrane Market Segmentation Analysis - By Application

The amniotic membrane market based on the application can be further segmented into Ophthalmology, Surgical Wounds Repairment, and Others. The ophthalmology segment held a dominant market share in the year 2021. It is owing to its properties that initiate a faster recovery time, while also substantially reducing the inflammation. Moreover, the amniotic membrane is also used to reduce scarring and post-operative eye cohesion stress. Additionally, the geriatric population is highly susceptible to having eye-related ailments, and the population of seniors in the demographic is increasing. For example, as per US CDC, the demographic demarcation of the seniors is growing, and by 2030, their segment would weigh close to 22%, which for now is 16%.

Additionally, the ophthalmology segment is estimated to be the fastest-growing, with a CAGR of 8.5% over the forecast period of 2022-2027. It is owing to a range of product innovations and discoveries stemming from the research in regenerative medicines, which will allow for better usage of amniotic membranes in the said segment.

Amniotic Membrane Market Segmentation Analysis - By Geography

The amniotic membrane market based on geography can be further segmented into North America, South America, Europe, Asia-Pacific, and the rest of the World. North America’s amniotic membrane held a dominant market share of 39% as compared to the other regions. It is owing to the region’s superior position in launching better products, which allows for the use in multiple applications. Additionally, the US government spent close to 5% or $175 billion in 2018 only for R&D in medical systems. Owing to such strategies and reimbursement policies under medical insurances, the market held a significant position.

However, Asia-Pacific is estimated to offer lucrative growth opportunities to marketers. It is owing to the surge in medical inventions, predominantly seen in the countries such as Korea, Japan, China, and India. Moreover, India saw an incremental budget allotment of 137% as compared to the previous year, to enhance the overall medical infrastructure. Owing to better policies and an improved outlook, the market is expected to grow at a steadfast pace in the projected period of 2022-2027.

Amniotic Membrane Market Drivers

The use of sutureless AMs in promoting and healing ocular surface conditions has readily aided the market growth

The use of sutureless technology has the potential to promote the overall healing process of the surface conditions which have stemmed owing to corneal scarring and people not responding to other treatments. For example, Keratitis, an inflammatory condition of the cornea which covers the pupil and iris can be created from infectious sources and non-infectious sources. In the case of the former, an antibiotic treatment course is recommended, however, in the case of the latter the keratitis can be created owing to contact lens overwear, auto-immune disease, and even dry-eye. The auto-immune keratitis most commonly occurs in patients suffering from rheumatoid arthritis. In the US, out of every 100,000 people, 71 are diagnosed with the following arthritis form, additionally, 1.5 million Americans have rheumatoid arthritis. Neurotrophic keratitis is again a serious condition, which can be caused by corneal nerve damage. Moreover, the former form is a result of a trauma or herpetic infection. Further, the following form of keratitis can be of utmost difficulty to handle. Hence, early intervention of AM can be used to facilitate faster wound healing and avoid complications such as corneal meal or even scar formation.

The growing number of ASCs has readily supplemented the market growth

ASCs or Ambulatory Surgical Centers have been growing in numbers for over a decade. In 2010, there were close to 5000 ASCs in the states of the US, however, they have now zoomed to around 10,000. The Medicare which is certified by ASCs, particularly in ophthalmology stands at the position of three, only after “orthopedic” and “pain.” Substantially, in a single specialty ASCs, a share of 25% is being kept reserved by the ophthalmology department. Since the geriatric population is more susceptible to having ocular diseases, the ASCs have bloomed. Moreover, the senior population prefers the following setup for any procedures as they are cost-sensitive, allow the patient to return on the same day, and also the chances of catching an SSIs are relatively low. Lastly, the government of the US plans to save around $22 billion by the use of ASC, under the American Rescue Plan, moreover, the Association of ASCs predict that they can help the Medicare program in saving up to $58 billion over the next decade. Owing to such parameters, the market is estimated to grow.

Amniotic Membrane Market Challenges

The post-operative challenges have been a market growth dampener

The use of AMs has been of excessive use in the medical field, particularly in, ophthalmology for more than decades, there have been cases where postoperative complications. Corneal abrasions might arise from the lid speculum, forceps, or a very aggressive application or removal of an older version of cryopreserved AM. Moreover, patients might report an increased foreign body sensation and even discomfort which can range from severe to mild. Poor Cornea-contract lens relationship can make the overall application of AM unsuccessful. If a contracting lens is too tight it can cause impingement of the limbal stem cell region, which can exacerbate issues with a healing corneal epithelium. Owing to such disadvantages, the market faces a ready market challenge.

Amniotic Membrane Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in this market. Amniotic Membrane top 10 companies include:

  1. Amnio Technology LLC
  2. Celularity Inc.
  3. Human Regenerative Technologies LLC
  4. Katena Products Inc.
  5. MiMedx
  6. Integra LifeSciences Corporation
  7. Skye Biologics Inc.
  8. Amniox Medical Inc.
  9. Smith And Nephew
  10. Life Cell International Pvt Ltd.

Recent Developments

  • In November 2021, MIMEDX demonstrated that its dehydrated human amnion chorion membrane usually outperforms the standard care in select Mohs defect reconstructions. The product- PURION, has an associated lower risk of SSIs, poor scar cosmesis, scar revision, and additional operation at the index site when compared to other incisional repairs. Mohs micrographic surgeries are increasing in number owing to an increase in the cutaneous malignancies in the aged population.
  • In May 2021, MIMEDX announced a collaborative agreement with Wake Forest Institute Regenerative Medicines. The collaboration focus to develop synergy between the companies shared vision of advancing the use of amniotic membranes in making regenerative medicines. Further, advance scientific evidence in support of safe and effective clinical therapies and restore quality of life for patients and is geared to further understanding product mechanisms of action and potential therapeutic targets.
  • In February 2020, Integra Life-Sciences Holding Corporation launched its Amnio-Excel Plus Placental Allograft Membrane. It is the latest addition to help in repairing any soft-tissue repair procedure. AmnioExcel Plus is a next-generation, thicker, tri-layer, non-side-specific allograft consisting of amnion-chorion-amnion layers that aids in creating an environment to help close complex wounds. The proprietary DryFlex processing technology preserves the inherent growth factors, cytokines, and extracellular matrix (ECM) found in native placental tissue.

Relevant Titles

Eye Infections Treatment Market- Forecast (2022-2027)
Report Code- HCR 0209

Eye Drop Lubricants Market-Forecast (2022-2027)
Report Code- HCR 94497 

For more Lifesciences and Healthcare related reports, please click here

1. Amniotic Membrane Market Overview
    1.1 Definitions and Scope
2. Amniotic Membrane Market- Executive Summary
3. Amniotic Membrane Market – Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Amniotic Membrane Market – Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Amniotic Membrane Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Amniotic Membrane Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Amniotic Membrane Market – By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Amniotic Membrane Market- By Type (Market Size –$Million/$Billion) 
    8.1 Cryopreserved Amniotic Membrane
    8.2 Dehydrated Amniotic Membrane
9. Amniotic Membrane Market- By Application (Market Size –$Million/$Billion) 
    9.1 Ophthalmology
    9.2 Surgical Wound Repairment
    9.3 Others
10. Amniotic Membrane Market- By End-Users (Market Size –$Million/$Billion) 
    10.1 Hospitals
    10.2 Private Clinics
    10.3 Ambulatory Surgical Centers
    10.4 Others
11. Amniotic Membrane Market - By Geography (Market Size -$Million/Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Amniotic Membrane Market - Market Entropy
    12.1 New product launches
    12.2 M&A's, collaborations, JVs, and partnerships
13. Amniotic Membrane Market – Industry Competition Landscape (Premium)
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key Companies
        13.1.3 Market Share by Countries – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14. Amniotic Membrane Market – Key Company List by Country Premium (Premium)
15. Amniotic Membrane Market - Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies

LIST OF TABLES

1.Global Amniotic Membrane Market By Product Market 2019-2024 ($M)
1.1 Cryopreserved Amniotic Membrane Market 2019-2024 ($M) - Global Industry Research
1.2 Lyophilization Amniotic Membrane Market 2019-2024 ($M) - Global Industry Research
2.Global Amniotic Membrane Market By End-User Market 2019-2024 ($M)
2.1 Hospital Market 2019-2024 ($M) - Global Industry Research
2.2 Ambulatory Surgical Center Market 2019-2024 ($M) - Global Industry Research
2.3 Specialized Clinic Market 2019-2024 ($M) - Global Industry Research
2.4 Research Center Laboratory Market 2019-2024 ($M) - Global Industry Research
3.Global Amniotic Membrane Market By Product Market 2019-2024 (Volume/Units)
3.1 Cryopreserved Amniotic Membrane Market 2019-2024 (Volume/Units) - Global Industry Research
3.2 Lyophilization Amniotic Membrane Market 2019-2024 (Volume/Units) - Global Industry Research
4.Global Amniotic Membrane Market By End-User Market 2019-2024 (Volume/Units)
4.1 Hospital Market 2019-2024 (Volume/Units) - Global Industry Research
4.2 Ambulatory Surgical Center Market 2019-2024 (Volume/Units) - Global Industry Research
4.3 Specialized Clinic Market 2019-2024 (Volume/Units) - Global Industry Research
4.4 Research Center Laboratory Market 2019-2024 (Volume/Units) - Global Industry Research
5.North America Amniotic Membrane Market By Product Market 2019-2024 ($M)
5.1 Cryopreserved Amniotic Membrane Market 2019-2024 ($M) - Regional Industry Research
5.2 Lyophilization Amniotic Membrane Market 2019-2024 ($M) - Regional Industry Research
6.North America Amniotic Membrane Market By End-User Market 2019-2024 ($M)
6.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
6.2 Ambulatory Surgical Center Market 2019-2024 ($M) - Regional Industry Research
6.3 Specialized Clinic Market 2019-2024 ($M) - Regional Industry Research
6.4 Research Center Laboratory Market 2019-2024 ($M) - Regional Industry Research
7.South America Amniotic Membrane Market By Product Market 2019-2024 ($M)
7.1 Cryopreserved Amniotic Membrane Market 2019-2024 ($M) - Regional Industry Research
7.2 Lyophilization Amniotic Membrane Market 2019-2024 ($M) - Regional Industry Research
8.South America Amniotic Membrane Market By End-User Market 2019-2024 ($M)
8.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
8.2 Ambulatory Surgical Center Market 2019-2024 ($M) - Regional Industry Research
8.3 Specialized Clinic Market 2019-2024 ($M) - Regional Industry Research
8.4 Research Center Laboratory Market 2019-2024 ($M) - Regional Industry Research
9.Europe Amniotic Membrane Market By Product Market 2019-2024 ($M)
9.1 Cryopreserved Amniotic Membrane Market 2019-2024 ($M) - Regional Industry Research
9.2 Lyophilization Amniotic Membrane Market 2019-2024 ($M) - Regional Industry Research
10.Europe Amniotic Membrane Market By End-User Market 2019-2024 ($M)
10.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
10.2 Ambulatory Surgical Center Market 2019-2024 ($M) - Regional Industry Research
10.3 Specialized Clinic Market 2019-2024 ($M) - Regional Industry Research
10.4 Research Center Laboratory Market 2019-2024 ($M) - Regional Industry Research
11.APAC Amniotic Membrane Market By Product Market 2019-2024 ($M)
11.1 Cryopreserved Amniotic Membrane Market 2019-2024 ($M) - Regional Industry Research
11.2 Lyophilization Amniotic Membrane Market 2019-2024 ($M) - Regional Industry Research
12.APAC Amniotic Membrane Market By End-User Market 2019-2024 ($M)
12.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
12.2 Ambulatory Surgical Center Market 2019-2024 ($M) - Regional Industry Research
12.3 Specialized Clinic Market 2019-2024 ($M) - Regional Industry Research
12.4 Research Center Laboratory Market 2019-2024 ($M) - Regional Industry Research
13.MENA Amniotic Membrane Market By Product Market 2019-2024 ($M)
13.1 Cryopreserved Amniotic Membrane Market 2019-2024 ($M) - Regional Industry Research
13.2 Lyophilization Amniotic Membrane Market 2019-2024 ($M) - Regional Industry Research
14.MENA Amniotic Membrane Market By End-User Market 2019-2024 ($M)
14.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
14.2 Ambulatory Surgical Center Market 2019-2024 ($M) - Regional Industry Research
14.3 Specialized Clinic Market 2019-2024 ($M) - Regional Industry Research
14.4 Research Center Laboratory Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Amniotic Membrane Market Revenue, 2019-2024 ($M)
2.Canada Amniotic Membrane Market Revenue, 2019-2024 ($M)
3.Mexico Amniotic Membrane Market Revenue, 2019-2024 ($M)
4.Brazil Amniotic Membrane Market Revenue, 2019-2024 ($M)
5.Argentina Amniotic Membrane Market Revenue, 2019-2024 ($M)
6.Peru Amniotic Membrane Market Revenue, 2019-2024 ($M)
7.Colombia Amniotic Membrane Market Revenue, 2019-2024 ($M)
8.Chile Amniotic Membrane Market Revenue, 2019-2024 ($M)
9.Rest of South America Amniotic Membrane Market Revenue, 2019-2024 ($M)
10.UK Amniotic Membrane Market Revenue, 2019-2024 ($M)
11.Germany Amniotic Membrane Market Revenue, 2019-2024 ($M)
12.France Amniotic Membrane Market Revenue, 2019-2024 ($M)
13.Italy Amniotic Membrane Market Revenue, 2019-2024 ($M)
14.Spain Amniotic Membrane Market Revenue, 2019-2024 ($M)
15.Rest of Europe Amniotic Membrane Market Revenue, 2019-2024 ($M)
16.China Amniotic Membrane Market Revenue, 2019-2024 ($M)
17.India Amniotic Membrane Market Revenue, 2019-2024 ($M)
18.Japan Amniotic Membrane Market Revenue, 2019-2024 ($M)
19.South Korea Amniotic Membrane Market Revenue, 2019-2024 ($M)
20.South Africa Amniotic Membrane Market Revenue, 2019-2024 ($M)
21.North America Amniotic Membrane By Application
22.South America Amniotic Membrane By Application
23.Europe Amniotic Membrane By Application
24.APAC Amniotic Membrane By Application
25.MENA Amniotic Membrane By Application
26.Alliqua Biomedical Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Amnio Technology, Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Applied Biologics Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Fziomed Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Human Regenerative Technologies, Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Integra Lifesciences Holding Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Katena Products, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Mimedx Group Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Skye Biologics Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Tissue-Tech Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)